Tianbao Lu
ScholarGPS® ID: 53250375529751
Affiliation History
Discipline
Chemistry
Top Specialties
Medicinal Chemistry | Drug Design | Chemical Synthesis | New Class | Cancer | Chemical Biology | Oral Administration
Metrics Summary
Publication Count
64
Predicted Citations
2,467
Predicted h-index
27
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease (journal article) Bioorganic & Medicinal Chemistry Letters, volume 29, issue 23, pages 126743- (2019). |
Design, synthesis and structure activity relationships of indazole and indole derivatives as potent glucagon receptor antagonists (journal article) Bioorganic & Medicinal Chemistry Letters, volume 29, issue 15, pages 1974-1980 (2019). |
Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy (journal article) Bioorganic & Medicinal Chemistry Letters, volume 28, issue 12, pages 2159-2164 (2018). |
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors (journal article) Bioorganic & Medicinal Chemistry Letters, volume 26, issue 17, pages 4216-4222 (2016). |
Journal of Medicinal Chemistry, volume 53, issue 4, pages 1843-1856 (2010). |
Patent Number: 7550474 (2009) |
Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif (journal article) Bioorganic & Medicinal Chemistry Letters, volume 18, issue 9, pages 2865-2870 (2008). |
7-Fluoroindazoles as Potent and Selective Inhibitors of Factor Xa (journal article) Journal of Medicinal Chemistry, volume 51, issue 2, pages 282-297 (2008). |
2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors (journal article) Bioorganic & Medicinal Chemistry Letters, volume 17, issue 22, pages 6266-6269 (2007). |
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity (journal article) Bioorganic & Medicinal Chemistry Letters, volume 16, issue 13, pages 3463-3468 (2006). |
Exploration of Potential Prodrugs of RWJ‐445167, an Oxyguanidine‐based Dual Inhibitor of Thrombin and Factor Xa (journal article) Chemical Biology & Drug Design, volume 68, issue 1, pages 29-36 (2006). |
Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists (journal article) Bioorganic & Medicinal Chemistry Letters, volume 16, issue 12, pages 3115-3120 (2006). |
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design (journal article) Bioorganic & Medicinal Chemistry Letters, volume 16, issue 12, pages 3310-3314 (2006). |
Patent Number: 7029654 (2006) |
Patent Number: 7030110 (2006) |
Substituted 1,4‐Benzodiazepine‐2,5‐diones as α ‐Helix Mimetic Antagonists of the HDM2‐p53 Protein–Protein Interaction (journal article) Chemical Biology & Drug Design, volume 67, issue 3, pages 201-205 (2006). |
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo (journal article) Molecular Cancer Therapeutics, volume 5, issue 1, pages 160-169 (2006). |
1,4‐Benzodiazepine‐2,5‐diones as Small Molecule Antagonists of the HDM2—p53 Interaction: Discovery and SAR. (journal article) ChemInform, volume 36, issue 25 (2005). |
Patent Number: 6900231 (2005) |
Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists (journal article) Bioorganic & Medicinal Chemistry Letters, volume 15, issue 7, pages 1857-1861 (2005). |